• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.08% Nasdaq Up0.22%

    BG Medicine, Inc. (BGMD)

    0.61 Up 0.03(5.14%) Nov 27, 12:51PM EST
    ProfileGet Profile for:
    BG Medicine, Inc.
    880 Winter Street
    Suite 210
    Waltham, MA 02451
    United States - Map
    Phone: 781-890-1199
    Fax: 781-895-1119
    Website: http://www.bg-medicine.com

    Index Membership:N/A
    Industry:Medical Laboratories & Research
    Full Time Employees:7

    Business Summary 

    BG Medicine, Inc., a commercial stage company, engages in developing and commercializing diagnostic products used to guide the patients suffering from heart failure and related disorders. The company offers BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of atherothrombotic cardiovascular events, such as heart attack and ischemic stroke. It has license, development, and commercialization agreements with Abbott Laboratories, bioMérieux SA, Siemens Healthcare Diagnostics Inc., and Alere Inc. for the automated instrument versions of galectin-3 test; and a strategic collaboration with Abbott Laboratories to develop and commercialize galectin-3 assay kits, and related control kits and calibrators. The company was formerly known as Beyond Genomics, Inc. and changed its name to BG Medicine, Inc. in October 2004. BG Medicine, Inc. was founded in 2000 and is headquartered in Waltham, Massachusetts.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on BG Medicine, Inc.

    Corporate Governance 
    BG Medicine, Inc.’s ISS Governance QuickScore as of Jul 1, 2013 is 10. The pillar scores are Audit: 1; Board: 10; Shareholder Rights: 7; Compensation: 9.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
    Dr. Paul R. Sohmer M.D., 66
    Chief Exec. Officer, Pres and Director
    Dr. Noubar B. Afeyan Ph.D., 52
    Founder, Director, Chairman of Compensation Committee and Member of Nominating & Governance Committee
    Mr. Stephen P. Hall , 64
    Chief Financial Officer, Principal Accounting Officer, Exec. VP and Treasurer
    Dr. Aram Adourian Ph.D., 45
    Chief Scientific Officer and Sr. VP
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders